Shawn Qu, M.D., Ph.D.

Dr. Shawn Qu is Chief & Chief Expert of Endocrinology, Metabolism and Thyroid Center at SinoUnited Health. He has more than 40 years’ experience of clinical practice at nationally renowned hospitals (including ChangHai Hospital, ZhongShan Hospital, and Shanghai Tenth People’s Hospital). He specializes in the diagnosis and treatment of complicated diseases such as thyroid diseases and metabolic disorders (including Obesity, Diabetes Mellitus, Fatty Liver Disease, etc.). Dr. Qu initiated the center-based management style for thyroid and metabolic disorders in China. He serves as a distinguished visiting professor and chief specialist at multiple Chinese colleges and institutions. Meanwhile, he has been a visiting specialist at international clinics and institutions for many years.

Concurrently, Dr. Qu established the industry-leading Weight and Metabolic Management Center at Sino United Health. This center integrates an internationally advanced multidisciplinary medical team and adopts globally top-tier medical technologies and pharmaceutical management systems. It aims to provide scientific and precise diagnosis and treatment solutions for patients with overweight, obesity, and related metabolic disorders.

Dr. Qu has accumulated extensive experience in international medical care. From 2003 to 2008, he pursued further studies at Baylor College of Medicine and the University of Pittsburgh in the United States. Currently, he is a professional member of the American Thyroid Association.

Dr. Qu has been re-elected as a standing committee member of the Endocrinology Branch of the Chinese Medical Association for several terms; and has been elected as the leader of the Obesity Study Group under the Endocrinology Branch of the Chinese Medical Association, marking his core leadership position in the national academic field of obesity. Meanwhile, he has presided over multiple consensus-building efforts and clinical studies, advancing the development of the obesity treatment system.

Dr. Qu is the member of Editorial Board for Chinese Journal of Endocrinology and Metabolism, and International Journal of Endocrinology and Metabolism. He has secured over 30 research grants (including 5 from the National Natural Science Foundation of China - NSFC), published more than 200 SCI-indexed papers, and served as chief editor for over 10 monographs, including Obesity. As the primary contributor, he was awarded 5 prestigious prizes, including the Natural Science Award (Second Class) from the Ministry of Education of China and the Medical Science and Technology Award (Third Class) from the Chinese Medical Association. He spearheaded the development of key clinical guidelines: Multidisciplinary Clinical Consensus on Obesity (2021) and Guidelines for Long-Term Weight Management and Pharmacotherapy in Patients with Obesity (2024).

Dr. Qu has been awarded with several honorary titles, including “Leading Scientist of Shanghai”, “Leading Expert of Medicine”, and “Pujiang Talent of Shanghai”.